These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 12533968)
1. Bcl-2 immunohistochemical detection in prostate cancer. Sulik M; Guzińska-Ustymowicz K Rocz Akad Med Bialymst; 2002; 47():254-61. PubMed ID: 12533968 [TBL] [Abstract][Full Text] [Related]
2. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer. Sulik M; Guzińska-Ustymowicz K Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969 [TBL] [Abstract][Full Text] [Related]
3. Correlation between colorectal cancer Bcl-2 expression and tumour clinicopathological variables. Guzińska-Ustymowicz K; Famulski W; Stasiak-Barmuta A; Zalewski B; Sulkowska M Rocz Akad Med Bialymst; 2002; 47():246-53. PubMed ID: 12533967 [TBL] [Abstract][Full Text] [Related]
4. Utility of Bcl-2, P53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population. Goto T; Nguyen BP; Nakano M; Ehara H; Yamamoto N; Deguchi T Urology; 2008 Jul; 72(1):167-71. PubMed ID: 18384856 [TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
6. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Poulos CK; Daggy JK; Cheng L Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065 [TBL] [Abstract][Full Text] [Related]
7. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Yang G; Timme TL; Frolov A; Wheeler TM; Thompson TC Cancer; 2005 Mar; 103(6):1186-94. PubMed ID: 15712208 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy. Abaza R; Diaz LK; Laskin WB; Pins MR J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis in prostate cancer: bax correlation with stage. Amirghofran Z; Monabati A; Gholijani N Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714 [TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer. Prtilo A; Leach FS; Markwalder R; Kappeler A; Burkhard FC; Cecchini MG; Studer UE; Thalmann GN J Urol; 2005 Nov; 174(5):1814-8; discussion 1818. PubMed ID: 16217293 [TBL] [Abstract][Full Text] [Related]
12. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158 [TBL] [Abstract][Full Text] [Related]
13. Study of p53 protein expression in prostate cancer. Sulik M; Guzińska-Ustymowicz K; Darewicz B; Sulik A Folia Histochem Cytobiol; 2001; 39 Suppl 2():197-8. PubMed ID: 11820605 [TBL] [Abstract][Full Text] [Related]
14. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer? Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review. Qiu YQ; Leuschner I; Braun PM Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349 [TBL] [Abstract][Full Text] [Related]
16. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins. Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582 [TBL] [Abstract][Full Text] [Related]
17. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Boccon-Gibod LM; Dumonceau O; Toublanc M; Ravery V; Boccon-Gibod LA Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298 [TBL] [Abstract][Full Text] [Related]
18. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983 [TBL] [Abstract][Full Text] [Related]
19. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors. Bloom KD; Richie JP; Schultz D; Renshaw A; Saegaert T; D'amico AV Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484 [TBL] [Abstract][Full Text] [Related]
20. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]